当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3757107
自主品牌
已选条件
-
T6008CNX-2006CNX 2006；CNX2006
CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.
价 格：￥电议型 号：T6008产 地：中国大陆
-
T2369RociletinibAVL-301；CNX-419；CO-1686
Rociletinib is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity.
价 格：￥电议型 号：T2369产 地：中国大陆
-
T2302CNX-774CNX774；CNX 774
CNX-774 is a highly specific, irreversible, and orally active BTK inhibitor (IC50<1 nM).
价 格：￥电议型 号：T2302产 地：中国大陆
-
T2256CNX-13511-[4-[[2-(1H-吲唑-4-基)-4-(4-吗啉基)噻吩并[3,2-D]嘧啶-6-基]甲基]-1-哌嗪基]-6-甲基-5-庚烯-1,4-二酮；CNX 1351；CNX1351
CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.
价 格：￥电议型 号：T2256产 地：中国大陆
-
T10854CNX-500CNX-500
CNX-500 is a probe consisting of a covalent Btk inhibitor chemically linked to biotin. CNX-500 has inhibitory activity against Btk (IC50: 0.5 nM) and the ability to form a covalent bond with Btk. CNX-500 has low inhibitory effects on kinase EGFR and upstr
价 格：￥电议型 号：T10854产 地：美洲
-
T2256CNX-1351CNX-1351,CNX1351,CNX 1351
CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.
价 格：￥电议型 号：T2256产 地：美洲
-
T2302CNX-774CNX-774,CNX774,CNX 774
CNX-774 is a highly specific, irreversible, and orally active BTK inhibitor (IC50<1 nM).
价 格：￥电议型 号：T2302产 地：美洲
-
T2369RociletinibRociletinib,AVL-301,CNX-419
Rociletinib is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity.
价 格：￥电议型 号：T2369产 地：美洲
-
T6008CNX-2006CNX-2006,CNX2006,CNX 2006
CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.
价 格：￥电议型 号：T6008产 地：美洲
-
T6008CNX-2006；化合物CNX2006CNX 2006|||CNX2006；CNX 2006|||CNX2006
CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.
价 格：￥电议型 号：T6008产 地：中国大陆
-
T2369Rociletinib；化合物RociletinibAVL-301|||CNX-419|||CO-1686；AVL-301|||CNX-419|||CO-1686
Rociletinib (CNX-419) is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity.
价 格：￥电议型 号：T2369产 地：中国大陆
-
T2302CNX-774；化合物CNX-774CNX 774；CNX 774
CNX-774 is a highly specific, irreversible, and orally active BTK inhibitor (IC50<1 nM).
价 格：￥电议型 号：T2302产 地：中国大陆
-
T2256CNX-1351化合物CNX13511-[4-[[2-(1H-吲唑-4-基)-4-(4-吗啉基)噻吩并[3,2-D]嘧啶-6-基]甲基]-1-哌嗪基]-6-甲基-5-庚烯-1,4-二酮
CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.
价 格：￥电议型 号：T2256产 地：中国大陆
-
T14993Rociletinib hydrobromide；化合物 T14993AVL-301 hydrobromide|||CO-1686 (hydrobromide)|||CNX-419 hydrobrom
Rociletinib hydrobromide is an orally delivered inhibitor of the mutant form of EGFR kinase (Kis: 21.5 nM and 303.3 nM for EGFR L858R/T790M and EGFR WT).
价 格：￥电议型 号：T14993产 地：中国大陆
-
T10854CNX-500；化合物 T10854CNX-500
CNX-500 is a probe consisting of a covalent Btk inhibitor chemically linked to biotin. CNX-500 has inhibitory activity against Btk (IC50: 0.5 nM) and the ability to form a covalent bond with Btk. CNX-500 has low inhibitory effects on kinase EGFR and upstream Src-family kinases.
价 格：￥电议型 号：T10854产 地：中国大陆
